AMERICAN INTERNATIONAL GROUP, INC. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 107 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$46,000
+17.9%
34,166
-1.7%
0.00%
Q4 2018$39,000
-59.8%
34,768
-0.8%
0.00%
Q3 2018$97,000
-19.2%
35,035
+4.3%
0.00%
Q2 2018$120,000
+18.8%
33,604
+2.2%
0.00%
Q1 2018$101,000
-53.2%
32,892
-4.1%
0.00%
-100.0%
Q4 2017$216,000
-6.5%
34,298
+1.4%
0.00%0.0%
Q3 2017$231,000
+38.3%
33,826
+44.1%
0.00%0.0%
Q2 2017$167,000
-18.9%
23,481
+4.9%
0.00%0.0%
Q1 2017$206,000
+145.2%
22,390
+7.1%
0.00%
Q4 2016$84,000
-99.9%
20,904
-0.3%
0.00%
Q3 2016$80,269,000
-10.8%
20,958
+0.2%
0.00%
Q2 2016$89,982,000
-13.5%
20,926
-7.0%
0.00%
Q1 2016$104,000,000
-53.8%
22,4950.0%0.00%
-100.0%
Q4 2015$225,000,000
+133828.6%
22,495
-0.2%
0.00%0.0%
Q3 2015$168,000
-100.0%
22,532
+0.1%
0.00%
-75.0%
Q2 2015$1,067,732,000
+64.3%
22,507
+26.9%
0.00%
+33.3%
Q1 2015$649,774,000
-7.7%
17,7340.0%0.00%0.0%
Q4 2014$704,217,000
+129.0%
17,734
+15.1%
0.00%
+200.0%
Q3 2014$307,469,000
+47.8%
15,412
-0.1%
0.00%0.0%
Q2 2014$208,056,000
+100.3%
15,423
+61.7%
0.00%
Q1 2014$103,869,000
-17.5%
9,538
+2.5%
0.00%
-100.0%
Q4 2013$125,858,000
+43.2%
9,309
+20.6%
0.00%
Q3 2013$87,865,0007,7210.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2015
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 354,300$7,068,0002.77%
Opaleye Management Inc. 169,700$3,385,515,0002.64%
Broadfin Capital, LLC 959,247$19,137,0002.01%
Novo Holdings A/S 900,000$17,955,0001.75%
Eventide Asset Management 300,900$6,003,0000.84%
EAM Investors, LLC 152,595$3,044,0000.62%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 497,858$9,932,0000.51%
Granite Point Capital Management, L.P. 40,000$798,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,191$8,981,0000.33%
TFS CAPITAL LLC 133,070$2,655,0000.23%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders